[Antihypertensive drugs acting through neurogenic mechanisms]

Therapeutic use of release-modifying drugs.

Handbook of experimental pharmacology·2007

History and nomenclature of alpha1-adrenoceptors.

European urology·1999

Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas.

Journal of affective disorders·1999

Development of an inducible NMDA receptor stable cell line with an intracellular Ca2+ reporter.

European journal of pharmacology·1999

Nomenclature and state of the art on alpha1-adrenoceptors.

European urology·1998

25 years since the discovery of presynaptic receptors: present knowledge and future perspectives.

Trends in pharmacological sciences·1997

[Guide to approaching the first demyelinating event in pediatrics].

Medicina·2026

[Recommendations for the diagnosis and treatment of optic neuromyelitis in children and adolescents].

Medicina·2026

[Disease associated with anti-myelin oligodendrocyte glycoprotein (MOGAD)].

Medicina·2026

[Update guide on pediatric multiple sclerosis].

Medicina·2026

[Guidelines for Serotonin Syndrome in Pediatrics].

Medicina·2026

[Neuroleptic Malignant Syndrome].

Medicina·2026

Aortic root-based ablation of para-Hisian atrial tachycardia: Acute and long-term outcomes from a consecutive series.

Heart rhythm O2·2026

Neurophysiological Monitoring during Surgery on the Central Nervous System: The Role of Evoked Responses.

International journal of anesthesiology & research·2026

Atherosclerosis in Rheumatoid Arthritis: The Role of NETs and Management.

Journal of inflammation research·2026

The perioperative brain-heart-immune axis: autonomic resilience, multimodal monitoring and postoperative delirium.

Frontiers in medicine·2026

Proteomics of aging: biomarkers for physiological systems and diseases.

Frontiers in aging·2026

Discovery of Ro 41-0960, a Non-Steroidal Inhibitor of the Na+/K+-ATPase.

ChemMedChem·2026

Related Experiment Videos

[Antihypertensive drugs acting through neurogenic mechanisms]

Related Concept Videos

Therapeutic use of release-modifying drugs.

History and nomenclature of alpha1-adrenoceptors.

Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas.

Development of an inducible NMDA receptor stable cell line with an intracellular Ca2+ reporter.

Nomenclature and state of the art on alpha1-adrenoceptors.

25 years since the discovery of presynaptic receptors: present knowledge and future perspectives.

[Guide to approaching the first demyelinating event in pediatrics].

[Recommendations for the diagnosis and treatment of optic neuromyelitis in children and adolescents].

[Disease associated with anti-myelin oligodendrocyte glycoprotein (MOGAD)].

[Update guide on pediatric multiple sclerosis].

[Guidelines for Serotonin Syndrome in Pediatrics].

[Neuroleptic Malignant Syndrome].

Aortic root-based ablation of para-Hisian atrial tachycardia: Acute and long-term outcomes from a consecutive series.

Neurophysiological Monitoring during Surgery on the Central Nervous System: The Role of Evoked Responses.

Atherosclerosis in Rheumatoid Arthritis: The Role of NETs and Management.

The perioperative brain-heart-immune axis: autonomic resilience, multimodal monitoring and postoperative delirium.

Proteomics of aging: biomarkers for physiological systems and diseases.

Discovery of Ro 41-0960, a Non-Steroidal Inhibitor of the Na+/K+-ATPase.

Related Experiment Videos

[Antihypertensive drugs acting through neurogenic mechanisms]

Related Concept Videos

Related Articles